Wang CJ et al. – The present study demonstrated for the first time the potential antitumor activity of interferon (IFN)–alpha combined with the oncolytic adenovirus SG600–IL–24 in hepatocellular carcinoma (HCC) both in vitro and in vivo, and suggests its further development as a potential candidate for HCC cancer gene therapy. [more...]
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close